GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.

about

LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse.Ovarian and Uterine Functions in Female Survivors of Childhood Cancers.C-Abl is not actıvated in DNA damage-induced and Tap63-mediated oocyte apoptosıs in human ovary

P2860

Q37602870-CBBE184B-05D5-46ED-8693-9BD2281F7B30 Q47574871-432FDA78-9A14-4098-BD04-DDACE971DF81 Q58712202-4161294A-9829-47AE-B34C-F70427518E0F

P2860

GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.

Item

http://www.wikidata.org/entity/Q40432160

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

GnRH agonist leuprolide acetat ...... herapy and radiation in vitro.

@en

type

Item

label

GnRH agonist leuprolide acetat ...... herapy and radiation in vitro.

@en

prefLabel

GnRH agonist leuprolide acetat ...... herapy and radiation in vitro.

@en

P1476

GnRH agonist leuprolide acetat ...... therapy and radiation in vitro

@en

P2093

Akira Iwase

http://www.w3.org/2001/XMLSchema#string

Basak Balaban

http://www.w3.org/2001/XMLSchema#string

Bulent Urman

http://www.w3.org/2001/XMLSchema#string

Cagatay Taskiran

http://www.w3.org/2001/XMLSchema#string

Cem Ayhan

http://www.w3.org/2001/XMLSchema#string

Ebru Alper

http://www.w3.org/2001/XMLSchema#string

Filiz Senbabaoglu

http://www.w3.org/2001/XMLSchema#string

Gizem Nur Sahin

http://www.w3.org/2001/XMLSchema#string

Kayhan Yakin

http://www.w3.org/2001/XMLSchema#string

Mustafa Cetiner

http://www.w3.org/2001/XMLSchema#string

P2860

Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation

Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review

How do chemotherapeutic agents damage the ovary?

Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.

Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.

Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer.

The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer.

Understanding follicle growth in vivo.

Options of fertility preservation in female cancer patients.

P304

2912-2925

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMREP/DEV257

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gamze Bildik

Ugur Selek

Nazlı Akin

P577

2015-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26466909

http://www.w3.org/2001/XMLSchema#string

GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.

about

P2860

P2860

GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698